Benefits Over Five Years of Ixekizumab Treatment in Patients With Psoriasis Involving Challenging Body Areas.
Gottlieb AB, Armstrong A, Blauvelt A, Griffiths CEM, Pinter A, Gooderham M, Lomaga M, Burge RT, Konicek BW, McDonald MF, See K, McKean-Matthews M, Mabuchi T.
Gottlieb AB, et al. Among authors: burge rt.
J Drugs Dermatol. 2024 Aug 1;23(8):619-625. doi: 10.36849/JDD.8160.
J Drugs Dermatol. 2024.
PMID: 39093657
Clinical Trial.